WHO Chief Scientist stressed that a pandemic requires multicountry and collaborative platform trials. "...an adaptive design where we bring on drugs to test...do it in very large sample size, an look at endpoints which are of public health importance like mortality," she said.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3eatNmc
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» COVID-19: India one of the largest contributors of global solidarity trial, says WHO Chief Scientist
https://ift.tt/eA8V8J
No comments:
Post a Comment